Atrium Therapeutics, Inc. (RNA) Options Chain
The options chain displays all available contracts with end-of-day quotes, Greeks, volume, and open interest for each strike and expiration, and streams live quotes for traders who connect a broker. It is the primary tool for options trade selection.
Atrium Therapeutics, Inc. (RNA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $128.5M, listed on NASDAQ, employing roughly 511 people, carrying a beta of 0.37 to the broader market. Atrium Therapeutics, Inc. Led by Kathleen Gallagher, public since 2026-02-27.
Snapshot as of Nov 13, 2026.
- Spot Price
- $7.66
- Total OI
- 13.6K
- Total Volume
- 0
- Front Expiration
- 35 days
- Second Expiration
- 63 days
- Avg Bid/Ask Spread
- 0.13%
Exposures are the assumed dealer book over the expirations within 30 days of the session, or the first four when none are (3 expirations, through Jan 21, 2028), as of Nov 13, 2026. Assumes dealers are long the calls and short the puts, a share p of open interest each - here 100% of open interest (the GEX page sets the share). A date without a stored exposure is a gap; a value marked * is partial, averaged over fewer days, or may include contracts expiring that day or of an unreadable expiration: its reason is printed beside it.
As of Nov 13, 2026, Atrium Therapeutics, Inc. (RNA) has 13.6K open contracts and 0 contracts traded. The nearest expiration is 35 days out, followed by 63 days. Average bid/ask spread across the chain is 0.13%: tight liquidity, suitable for active strategies. The options chain aggregates every listed strike and expiration, letting traders evaluate skew, term structure, and liquidity in a single view.
How RNA options chain Data Feeds Strategy Selection
Strategy selection on Atrium Therapeutics, Inc. options does not derive from any single metric in isolation. The options chain view above sits inside a broader read: ATM IV varies by tenor and the assumed dealer book's GEX is negative, so its hedging amplifies directional moves. Combine the options chain data here with the volatility-skew surface, gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.
How to read the RNA chain depth
Front-month expirations carry the most volume, the highest gamma, and the tightest bid-ask spreads; longer-dated tenors carry less liquidity but more vega exposure. RNA front expiration sits at 35 days - the typical hedging horizon for monthly options.
RNA chain mechanics and execution
Options are listed at standardized strike intervals (typically $1 for sub-$25 underlyings, $2.50-$5 for mid-cap, $10-$50 for large-cap), and the deltas of each listed strike are determined by where IV lies relative to the strike's moneyness. Average bid/ask spread on the RNA chain is 0.13% - a measure of liquidity. Tighter spreads on liquid strikes mean lower transaction costs; wider spreads on long-dated or far-OTM strikes mean execution drag can dominate the math. The chain table on the SPA side shows the full per-strike, per-expiration grid; this SSR page summarizes the listed expirations and the front-month context to anchor the structural read.
Using the RNA chain to build structures
Strategy selection starts with the chain: directional theses use single-leg calls or puts, range-bound theses use credit spreads or iron condors, vol theses use straddles or strangles, calendar theses use diagonal spreads. Cross-reference with the gamma-exposure profile to understand where the assumed book's hedging would reinforce or fight your position, and with the volatility-skew chart to confirm the strikes you're trading sit at the IV levels your strategy assumes.
Learn how the options chain is reported and how to read the data →
Frequently asked RNA options chain questions
- What does the RNA options chain show right now?
- As of Nov 13, 2026, Atrium Therapeutics, Inc. (RNA) has 13.6K contracts outstanding and 0 traded today. The full chain spans every listed strike and expiration with bid/ask, Greeks, volume, and open interest per contract.
- What expirations are available for RNA options?
- The nearest expiration is 35 days out, followed by 63 days. Listed expirations typically extend monthly with weeklies between, plus LEAPS one to two years out for liquid names.
- How tight are RNA options bid/ask spreads?
- Average bid/ask spread across the chain is 0.13%. Tight liquidity supports active strategies including ratio spreads and fly structures.